6,953
Views
36
CrossRef citations to date
0
Altmetric
Review

Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system

, , &
Pages 45-63 | Received 13 Sep 2020, Accepted 04 Nov 2020, Published online: 04 Dec 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Siddhartha Dutta, Rima B Shah, Shubha Singhal, Sudeshna Banerjee Dutta, Sumit Bansal, Susmita Sinha & Mainul Haque. (2023) Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes. Drug Design, Development and Therapy 17, pages 1907-1932.
Read now

Articles from other publishers (35)

Pariya Khodabakhsh, Afsaneh Asgari Taei, Hamed Shafaroodi, Safura Pournajaf & Leila Dargahi. (2023) Effect of Metformin on Epidermal Neural Crest Stem Cells and Their Potential Application in Ameliorating Paclitaxel-induced Neurotoxicity Phenotype. Stem Cell Reviews and Reports.
Crossref
Yan Ma, Qian Jiang, Bingxin Yang, Xiaoyu Hu, Gang Shen, Wei Shen & Jing Xu. (2023) Platelet mitochondria, a potent immune mediator in neurological diseases. Frontiers in Physiology 14.
Crossref
Kyung Hoon Sun, Cheol Hee Choi, Gwang-Won Cho & Chul Ho Jang. (2023) Effect of Metformin on the Functional and Electrophysiological Recovery of Crush Injury-Induced Facial Nerve Paralysis in Diabetic Rats. Journal of Personalized Medicine 13:9, pages 1317.
Crossref
Hala M. Bakry, Noha O. Mansour, Tawfik R. ElKhodary & Moetaza M. Soliman. (2023) Efficacy of metformin in prevention of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled trial. Frontiers in Pharmacology 14.
Crossref
Kelley C. Atkinson, Marvellous Osunde & Seema K. Tiwari-Woodruff. (2023) The complexities of investigating mitochondria dynamics in multiple sclerosis and mouse models of MS. Frontiers in Neuroscience 17.
Crossref
Fatemeh Karami, Hamidreza Jamaati, Natalie Coleman-Fuller, Maryam Shokrian Zeini, A. Wallace Hayes, Mina Gholami, Mahsa Salehirad, Mohammad Darabi & Majid Motaghinejad. (2023) Is metformin neuroprotective against diabetes mellitus-induced neurodegeneration? An updated graphical review of molecular basis. Pharmacological Reports 75:3, pages 511-543.
Crossref
Ying Dong, Yingbei Qi, Haowen Jiang, Tian Mi, Yunkai Zhang, Chang Peng, Wanchen Li, Yongmei Zhang, Yubo Zhou, Yi Zang & Jia Li. (2023) The development and benefits of metformin in various diseases. Frontiers of Medicine 17:3, pages 388-431.
Crossref
Amany AA Atia, Rehab H Ashour, Marwa MAF Zaki, Karawan MA Rahman & Nehal M Ramadan. (2023) The comparative effectiveness of metformin and risperidone in a rat model of valproic acid-induced autism, Potential role for enhanced autophagy. Psychopharmacology 240:6, pages 1313-1332.
Crossref
Tian Jin, Yong Zhang, Benson O.A. Botchway, Min Huang, Qicheng Lu & Xuehong Liu. (2023) Quercetin activates the Sestrin2/AMPK/SIRT1 axis to improve amyotrophic lateral sclerosis. Biomedicine & Pharmacotherapy 161, pages 114515.
Crossref
Mahmoud Khaleghi-Mehr, Alireza-Azizzadeh Delshad, Sepideh Shafie-Damavandi & Mehrdad Roghani. (2023) Metformin mitigates amyloid β1-40-induced cognitive decline via attenuation of oxidative/nitrosative stress and neuroinflammation. Metabolic Brain Disease 38:4, pages 1127-1142.
Crossref
Toshiyuki Oshitari. (2023) Advanced Glycation End-Products and Diabetic Neuropathy of the Retina. International Journal of Molecular Sciences 24:3, pages 2927.
Crossref
Liang Zhang, Jing Zhang, Xiaoming Zhu, Wei Jiao, Yang Yang, Youping Wu, Likun Yang & Yuhai Wang. (2023) Metformin enhances neural precursor cells migration and functional recovery after ischemic stroke in mice. Experimental Brain Research 241:2, pages 505-515.
Crossref
Sara Marinelli. 2023. Diet and Nutrition in Neurological Disorders. Diet and Nutrition in Neurological Disorders 767 787 .
Nicola Paccione, Mahdieh Rahmani, Emilia Barcia & Sofía Negro. (2022) Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems. Pharmaceutics 15:1, pages 13.
Crossref
Yang Du, Ya-Juan Zhu, Yi-Xin Zhou, Jing Ding & Ji-Yan Liu. (2022) Metformin in therapeutic applications in human diseases: its mechanism of action and clinical study. Molecular Biomedicine 3:1.
Crossref
Gui Cao, Ting Gong, Yue Du, Yicun Wang, Tongtong Ge & Jingyu Liu. (2022) Mechanism of metformin regulation in central nervous system: Progression and future perspectives. Biomedicine & Pharmacotherapy 156, pages 113686.
Crossref
Rui Zhu, Ying Lei, Fangxiao Shi, Qing Tian & Xinwen Zhou. (2022) Arginine Reduces Glycation in γ2 Subunit of AMPK and Pathologies in Alzheimer’s Disease Model Mice. Cells 11:21, pages 3520.
Crossref
Ingrid Prata Mendonça, Igor Henrique Rodrigues de Paiva, Eduardo Pereira Duarte-Silva, Michel Gomes de Melo, Rodrigo S. da Silva, Maria Isabelly Xavier do Nascimento & Christina Alves Peixoto. (2022) Metformin improves depressive-like behavior in experimental Parkinson’s disease by inducing autophagy in the substantia nigra and hippocampus. Inflammopharmacology 30:5, pages 1705-1716.
Crossref
Xiao Qiu-Yue, Ye Tian-Yuan, Wang Xiao-Long, Qi Dong-Mei & Cheng Xiao-Rui. (2022) Effects of Metformin on Modulating the Expression of Brain-related Genes of APP/PS1 Transgenic Mice based on Single Cell Sequencing. Current Alzheimer Research 19:11, pages 754-771.
Crossref
Eftekhar EftekharpourPaul Fernyhough. (2022) Oxidative Stress and Mitochondrial Dysfunction Associated with Peripheral Neuropathy in Type 1 Diabetes. Antioxidants & Redox Signaling 37:7-9, pages 578-596.
Crossref
Ümit Kılıç, Şerif Demir, Ersin Beyazçiçek, Özge Beyazçiçek & Hayriye Soytürk. (2022) The Effects of Acute and Chronic Metformin Treatment on Penicillin Induced Epileptiform Activity in Rats. Journal of Academic Research in Medicine 12:2, pages 87-98.
Crossref
Md. Ohidur Rahman, Shaheen Ahmed, Tanoy Mazumder, Md. Abdus Salam, Prodip Kumar Baral, Md. Faruk Rana, Shuvo Mitra, Sayem Hossain, Rubiya Rahman & Md. Saddam Hussain. (2022) A comparative evaluation of cardiac and neurological safety status of two commonly used oral hypoglycaemic agents in T2-DM Swiss albino mice model. Metabolism Open 14, pages 100191.
Crossref
Amin Hasanvand. (2022) The role of AMPK-dependent pathways in cellular and molecular mechanisms of metformin: a new perspective for treatment and prevention of diseases. Inflammopharmacology 30:3, pages 775-788.
Crossref
Krish Chandrasekaran, Neda Najimi, Avinash R. Sagi, Sushuma Yarlagadda, Mohammad Salimian, Muhammed Ikbal Arvas, Ahmad F. Hedayat, Yanni Kevas, Anand Kadakia & James W. Russell. (2022) NAD+ Precursors Repair Mitochondrial Function in Diabetes and Prevent Experimental Diabetic Neuropathy. International Journal of Molecular Sciences 23:9, pages 4887.
Crossref
Mohamad-Reza Aghanoori, Prasoon Agarwal, Evan Gauvin, Raghu S. Nagalingam, Raiza Bonomo, Vinith Yathindranath, Darrell R. Smith, Yan Hai, Samantha Lee, Corinne G. Jolivalt, Nigel A. Calcutt, Meaghan J. Jones, Michael P. Czubryt, Donald W. Miller, Vernon W. Dolinsky, Virginie Mansuy-Aubert & Paul Fernyhough. (2022) CEBPβ regulation of endogenous IGF-1 in adult sensory neurons can be mobilized to overcome diabetes-induced deficits in bioenergetics and axonal outgrowth. Cellular and Molecular Life Sciences 79:4.
Crossref
Yajiang Yuan, Xiangyi Fan, Zhanpeng Guo, Zipeng Zhou & Weiran Gao. (2022) Metformin Protects against Spinal Cord Injury and Cell Pyroptosis via AMPK/NLRP3 Inflammasome Pathway. Analytical Cellular Pathology 2022, pages 1-11.
Crossref
Bruno Dutra Arbo, Lucia Emanueli Schimith, Michele Goulart dos Santos & Mariana Appel Hort. (2022) Repositioning and development of new treatments for neurodegenerative diseases: Focus on neuroinflammation. European Journal of Pharmacology 919, pages 174800.
Crossref
Youjia Fan, Rong Dong, Honghai Zhang, Buwei Yu & Han Lu. (2022) The Role of SIRT1 in Neuropathic Pain from the Viewpoint of Neuroimmunity. Current Pharmaceutical Design 28:4, pages 280-286.
Crossref
Jiang Du, Xinlei Liu, Yan Zhang, Xiaojing Han, Chunya Ma, Yanli Liu, Lihong Guan, Liang Qiao & Juntang Lin. (2022) The Effects of Combined Therapy With Metformin and Hydroxypropyl-β-Cyclodextrin in a Mouse Model of Niemann-Pick Disease Type C1. Frontiers in Pharmacology 12.
Crossref
Shiliang Ji, Xingxing Zhao, Ruifang Zhu, Yongchao Dong, Lifeng Huang & Taiquan Zhang. (2022) Metformin and the risk of dementia based on an analysis of 396,332 participants. Therapeutic Advances in Chronic Disease 13, pages 204062232211094.
Crossref
Moein Ala & Mahan Ala. (2021) Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next?. ACS Pharmacology & Translational Science 4:6, pages 1747-1770.
Crossref
Giovanni Tulipano. (2021) Integrated or Independent Actions of Metformin in Target Tissues Underlying Its Current Use and New Possible Applications in the Endocrine and Metabolic Disorder Area. International Journal of Molecular Sciences 22:23, pages 13068.
Crossref
Varda Shoshan-Barmatz, Uttpal Anand, Edna Nahon-Crystal, Marta Di Carlo & Anna Shteinfer-Kuzmine. (2021) Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?. Frontiers in Physiology 12.
Crossref
Mohammed Al Za’abi, Badreldin H. Ali, Yousuf Al Suleimani, Sirin A. Adham, Haytham Ali, Priyadarsini Manoj, Mohammed Ashique & Abderrahim Nemmar. (2021) The Effect of Metformin in Diabetic and Non-Diabetic Rats with Experimentally-Induced Chronic Kidney Disease. Biomolecules 11:6, pages 814.
Crossref
Pascual Sanz, José Maria Serratosa & Marina P. Sánchez. (2021) Beneficial Effects of Metformin on the Central Nervous System, with a Focus on Epilepsy and Lafora Disease. International Journal of Molecular Sciences 22:10, pages 5351.
Crossref